LOS ANGELES, CA / ACCESSWIRE / November 14, 2019 / International Cannabrands Inc. (CSE:INCB) (the “Company“) is pleased to announce the appointment of Peter Schmid to the Board of Advisors.
Mr. Peter Schmid is a veteran sales executive with over 25 years’ experience in luxury retail and merchandising and has honed his skills working with some of the most well-respected brands in fashion. He currently serves as Senior Account Executive for a luxury Italian menswear label and has led projects with retailers such a Bloomingdales to create in-store brand experiences. Throughout his career, Mr. Schmid has focused on driving continuous growth while overseeing multiple six-figure accounts.
Steve Gormley, CEO of the Company commented: “As ICL looks to develop CBD products and expand distribution of our CBD portfolio, Peter will lend invaluable expertise and can open doors to established retailers that may otherwise be unreceptive to CBD and cannabis brands. Peter has also seen the retail landscape evolve tremendously over his decades of experience, and his ability to anticipate and adapt to change in a rapidly shifting industry will provide us critical perspective as the cannabis sector matures.”
Mr. Schmid joins International Cannabrands eager to leverage his retail network and passion for wellness to bring CBD and cannabis products to a mainstream audience. Peter Schmidt commented: “The efficacy of CBD and its wide array of applications in health, wellness, and beauty present a massive, untapped opportunity. This category deserves to be elevated to appeal to discerning, high-end consumers.”
Together with his husband, Mr. Schmid also runs a health and wellness focused business called Rezalution Fitness Expeditions, a unique, immersive travel experience created for health-conscious travelers.
About International Cannabrands (ICI)
International Cannabrands is a CBD and cannabis focused brand portfolio, leveraging the potential of the plant by offering best of breed products that naturally complement today’s consumer lifestyles. The Company’s mission is to build and market a diversified portfolio of cannabis and CBD brands, with strategic manufacturing and distribution partnerships to support better EBITDA and margins. ICI markets products with THC content where that practice has been legalized at the state level through either medicinal or full recreational use. ICI also markets products containing CBD in the US and internationally. The Company believes as the legal cannabis and CBD markets evolve, high-quality, unique products will increasingly capture market share and provide a valuable platform for growth.
International Cannabrands Contact:
Steve Gormley Chief Executive Officer, 12655 W Jefferson Blvd, Los Angeles, CA, 90066 Ph: (323) 828-4321 or steve.gormley@intlcannabrands.com Media Inquiries: media@intlcannabrands.com.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Disclaimer concerning Forward-looking Statements
Certain statements included herein constitute “forward-looking statements” relating to the timing and execution of the Company’s revised strategy, within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Investors are cautioned not to put undue reliance on forward-looking statements. Additional risks and uncertainties regarding the Company are described in its publicly-available disclosure documents filed by the Company on SEDAR (www.sedar.com). The forward-looking statements contained in this news release represent the Company’s expectations as of the date of this news release, or as of the date they are otherwise stated to be made, and subsequent events may cause these expectations to change. Except as required by law, the Company does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.
SOURCE: International Cannabrands Inc.
View source version on accesswire.com:
https://www.accesswire.com/566574/International-Cannabrands-Announces-Key-Advisory-Board-Appointment
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…